Wendling, Daniel
Prati, Clément
Chouk, Mickael
Verhoeven, Frank
Article History
First Online: 26 May 2020
Compliance with Ethical Standards
:
: Daniel Wendling: Occasional interventions (speaking fees, advisory board): AbbVie, BMS, MSD, Pfizer, Roche Chugai, Amgen, Nordic Pharma, UCB, Novartis, Janssen, Celgene, Hospira, Lilly, Sandoz, Grunenthal. Indirect interests: Abbvie, Pfizer, Roche Chugai, MSD, UCB, Mylan, Fresenius Kabi.C Prati: Novartis, Lily and PfizerM Chouk: noneF Verhoeven: Novartis, MSD, Celgene, Amgen and BMS